Is it possible to model the risk of malignancy of focal abnormalities found at prostate multiparametric MRI?

European Radiology

Volumn 22, Issue 5, 2012, Pages 1149-1157

  Rouvière, Olivier ^a,b,c,e   Papillard, Matthieu ^a,b,c   Girouin, Nicolas ^a,b,c   Boutier, Romain ^a,b,c   Rabilloud, Muriel ^c,d   Riche, Benjamin ^c,d   Mège Lechevallier, Florence ^a   Colombel, Marc ^a   Gelet, Albert ^a,e  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e INSERM   (France)

Author keywords

Diffusion weighted MRI; Dynamic contrast enhanced MRI; MRI; Prostate biopsy; Prostate cancer

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SIZE; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER;

COMPUTER SIMULATION; FRANCE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84857860836     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2343-8     Document Type: Article

References (27)

1. Girouin N, Mege-Lechevallier F, Tonina Senes A et al (2007) Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? Eur Radiol 17:1498-509 (Pubitemid 46767598)
2. Futterer JJ, Heijmink SW, Scheenen TW et al (2006) Prostate Cancer Localization with Dynamic Contrast-enhanced MR Imaging and Proton MR Spectroscopic Imaging. Radiology 241:449-58 (Pubitemid 44632891)
3. Villers A, Puech P, Mouton D, Leroy X, Ballereau C, Lemaitre L (2006) Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 176:2432-7 (Pubitemid 44665992)
4. Yoshimitsu K, Kiyoshima K, Irie H et al (2008) Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology. J Magn Reson Imaging 27:132-9
5. Yoshizako T, Wada A, Hayashi T et al (2008) Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transitionzone cancer. Acta Radiol 49:1207-13
6. Lim HK, Kim JK, Kim KA, Cho KS (2009) Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection-a multireader study. Radiology 250:145-51
7. Puech P, Potiron E, Lemaitre L et al (2009) Dynamic contrastenhanced- magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. Urology 74:1094-9
8. Mazaheri Y, Shukla-Dave A, Hricak H et al (2008) Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging-correlation with pathologic findings. Radiology 246:480-8
9. Yuen JS, Thng CH, Tan PH et al (2004) Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 171:1482-6 (Pubitemid 38365401)
10. Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S (2007) Prostate cancer screening: the clinical value of diffusionweighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 25:146-52 (Pubitemid 46095209)
11. Cheikh AB, Girouin N, Colombel M et al (2009) Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy. Eur Radiol 19:770-8
12. Ahmed HU, Kirkham A, Arya M et al (2009) Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol 6:197-206
13. Heidenreich A (2011) Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. Eur Urol 59:495-7
14. Dickinson L, Ahmed HU, Allen C et al (2011) Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 59:477-94
15. Akin O, Sala E, Moskowitz CS et al (2006) Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 239:784-92 (Pubitemid 43830614)
16. McNeal JE, Haillot O (2001) Patterns of spread of adenocarcinoma in the prostate as related to cancer volume. Prostate 49:48-57
17. Haffner J, Potiron E, Bouye S et al (2009) Peripheral zone prostate cancers: location and intraprostatic patterns of spread at histopathology. Prostate 69:276-82
18. Lemaitre L, Puech P, Poncelet E et al (2009) Dynamic contrastenhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings. Eur Radiol 19:470-80
19. Bouye S, Potiron E, Puech P, Leroy X, Lemaitre L, Villers A (2009) Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology. Prostate 69:105-13
20. Franiel T, Hamm B, Hricak H (2011) Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer. Eur Radiol 21:616-26
21. Tan CH, Wang J, Kundra V (2011) Diffusion weighted imaging in prostate cancer. Eur Radiol 21:593-603
22. Jager GJ, Ruijter ET, van de Kaa CA et al (1996) Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 166:845-52 (Pubitemid 26102064)
23. Cornud F, Flam T, Chauveinc L et al (2002) Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology 224:203-10 (Pubitemid 34680396)
24. Franiel T, Stephan C, Erbersdobler A et al (2011) Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding - Multiparametric MR imaging for detection and biopsy planning. Radiology 259:162-72
25. Mozer P, Baumann M, Chevreau G et al (2009) Mapping of transrectal ultrasonographic prostate biopsies: quality control and learning curve assessment by image processing. J Ultrasound Med 28:455-60
26. Pinto PA, Chung PH, Rastinehad AR et al (2011) Magnetic Resonance Imaging/Ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric Magnetic Resonance imaging. J Urol 186:1281-1285
27. Delongchamps NB, Haas GP (2009) Saturation biopsies for prostate cancer: current uses and future prospects. Nat Rev Urol 6:645-52